Dr Andrea Cerase
Lecturer in Genomics and Epigenetics
Centre: Centre for Genomics and Child Health
Email: firstname.lastname@example.orgTelephone: 020 7882 2594
Andrea grew up in Procida, a little island in the bay of Naples, Italy. He studied Molecular Biology at the University of Naples Federico II and worked at the Italian National Cancer Institute for his thesis. He received his MSc degree in Molecular Biology (summa cum laude) in 2002. Subsequently, he joined Prof. Maurizio D’Esposito’s group at Institute of Genetics and Biophysics (IGB-National Council of Research, CNR), Naples, studying the role of chromatin and DNA modifications in cancer - and this was the time when his interest in epigenetics began. He decided to stay in D’Esposito’s lab to do his PhD, focusing on the epigenetic mechanism of SPRY3 gene silencing in humans.
As a part of his Doctoral training Andrea came to Prof. Neil Brockdorff’s lab at the Imperial College London in 2006 as a visiting graduate student. Here he became interested in X inactivation and decided to choose this topic for his postdoc. After having his viva and receiving his PhD degree, subsequently Andrea joined the Brockdorff lab at the University of Oxford. His project was to study the epigenetics of X chromosome inactivation, focusing on understanding how Xist mediates gene silencing. In particular, he was interested in the interplay between Xist and Polycomb Repressive Complexes. He proved that Xist and PRC2 do not interact directly, moving the balance of the much-debated Xist-mediated PRC2 recruitment model toward an indirect recruitment one. Building on this he set up a genome-wide RNAi screen to identify novel factors involved in X chromosome inactivation and run a set of screens. Based on his pioneering system the lab has identified important regulators of X inactivation. At the end of 2013 Andrea decided to move on with his career and returned to Italy. Back home, Andrea joined Prof. Phil Avner’s group at the EMBL-Rome as an EMBL-fellow to study the initiation phase of mouse X inactivation, in particular the role of chromatin remodelers in Xist and Tsix regulation.
In 2018 Andrea has started his-own laboratory at the Blizard Institute, Queen Mary University of London. His primary research focuses are epigenetics, X chromosome inactivation and lncRNAs.
He is actively involved in science divulgation since his time at the University of Oxford and he regularly writes for several magazines. He is acts as an editor for many journals and as a referee for Italian, UK and international body of funding and for several journals. He is an associate fellow of the Higher Education Academy (AFHEA).
The Cerase Lab is currently working in X Chromosome inactivation (XCI) and XCI reversal using complementary approaches. The lab is also interested in X-linked neurodevelopmental disorders such as Rett and CDKL5 syndromes. The lab long-term plan is to study the epigenetic basis of brain development in health and disease with a particular focus on the role of lncRNAs and chromatin architecture.
Teaching in Genomics, Epigenetics, lncRNAs, Molecular Biology.
Courses: Epigenetics, X-chromosome Inactivation
The lab research interests are in epigenetics, gene expression and nuclear organisation. These includes X chromosome Inactivation and reactivation, spatial control of gene expression and long non-coding RNAs at single gene and genome-wide level.
Line of research #1
XCI reversal, a small molecule screening
The human X-chromosome carries ~30% of genes associated to intellectual disabilities. Mutations of genes on the X-chromosome account for up to 20% of Autism Spectrum Disorders (ASDs). Epimutations on the X-chromosome have also been associated to a number of mental health conditions (i.e. depression, bipolar disorder, schizophrenia) and neurodegeneration. Female mammals silence one of the two X chromosomes in order to achieve dosage compensation to males by means of random X chromosome inactivation. As a consequence of this process, females carrying an X-linked mutation, silence either the mutated and the wild-type (WT) copy of the gene, generally in a 50-50 ratio. Therefore, females have a natural “reservoir” of non-mutated dormant genes that can be reactivated.
It is possible to reactivate “dormant” X-linked genes by drug-treatment that “deactivate” the master regulator of X inactivation, the long non-coding RNA (lncRNA) Xist. Reactivation of the dormant genes can normalize protein levels and result in functional phenotype rescue. In order to identify small molecules that can specifically block Xist RNA interaction with silencing partners or other Xist-specific functions. We will screen for compounds that reactivate the silent wild-type copy of MeCP2 and Cdkl5. Mutations of these genes are causative of Rett and CDKL5 syndromes, respectively, which are very debilitating ASD/intellectual-retardation diseases. Crucially, the diseases associated with mutations in these genes do not lead to neurodegeneration, which makes them curable in the post-natal/adult state, as shown by previous research.
Line of research #2
Discovery and characterization of novel classes of brain-specific lncRNAs
Work in cell lines and mouse models supports the hypothesis that lncRNAs are important mediators of cellular functions regulating different levels of gene expression. LncRNAs have been shown to work on four regulatory levels: i) as macromolecular scaffolding for protein recruitment; ii) as molecular sponges for sequestering regulatory ncRNAs, mRNA or proteins; iii) as a genomic 3D organizer; iv) as cis/trans-regulatory elements regulating transcription and RNA-splicing. A noticeable example of a multitasking lncRNA is Xist, the master regulator of X chromosome Inactivation (XCI).
lncRNA are fundamental regulators of gene expression. We believe that it is possible to hypothesize the existence of “master” lncRNAs regulating hundreds of genes during brain development.
The objective of this research is finding novel candidate lncRNAs that potentially regulate the expression of protein-coding genes controlling brain development and function. Of pivotal interest will be the analysis of lncRNAs associated with disease during brain development and as a function of environmental clues such as stress diet, chemicals, and aging.
Cerase lab is a part of QMUL Epigenetics Hub.
Research Group Member
Nerea Blane Ruiz, Research Technician
Cirillo D., Blanco M., Armaos A., Buness A., Avner P., Gutmann M., Cerase A* and Tartaglia G.*, Quantitative predictions of protein interactions with long non-coding RNA. Nature Methods, 2016 Dec 29;14(1):5-6 * Correspondent author.
Chen C.K., Blanco M., Jackson C., Aznauryan E., Ollikainen N., Surka C., Chow A., Cerase A., McDonel P., Guttman M. Xist recruits the X chromosome to the nuclear lamina to enable chromosome-wide silencing. Science, 2016 Oct 28;354(6311):468-472.
Moindrot B.*, Cerase A.*, Coker H., Masui O., Grizenhout A., Pintacuda G., Schermelleh L., Nesterova T.B., Pintacuta G., Brockdorff N. A pooled shRNA screen identifies Rbm15, Spen and Wtap as factors required for Xist RNA-mediated silencing. Cell Reports, 2015 Jul 28. *First author
Cerase A., Smeets D., Tang Y.A., Gdula M., Kraus F. Spivakov M., Moindrot B., Leleu M., Tattermusch A., Demmerle J., Nesterova T.B., Green C., Otte A.P., Schermelleh L. and Brockdorff N. Spatial separation of Xist-RNA and Polycomb proteins revealed by super resolution microscopy. Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2235-40
Cerase A.*, Pintacuta G., Tattermusch A. and Avner P*. Xist localization and function: New insights from multiple levels. Genome Biology, 2015 Aug 15;16:166 * Correspondent author.